About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Daily Archives: May 24, 2007
Compare and Contrast – EMEA and FDA on Avandia
The FDA issued a press release on the issuance of a safety alert on Avandia on May 21. On May 23, the European Medicines Agency (EMEA) also released a statement on Avandia safety. I thought it interesting to compare the … Continue reading
Posted in Drug Safety, FDA Image
2 Comments